Mammalian Genome

, Volume 23, Issue 3–4, pp 241–249 | Cite as

A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency

  • Gillian L. McNab
  • Timothy R. Dafforn
  • Alice Wood
  • Elizabeth Sapey
  • Robert A. Stockley


Animal models that closely resemble human disease can present a challenge. Particularly so in alpha-1 antitrypsin deficiency (α1ATD), as the mouse alpha-1 antitrypsin (α1AT) cluster encodes five highly related genes compared with the one in humans. The mouse PI2 homologue is closest to the α1AT human gene. We have changed the equivalent mouse site that results in the Z variant in man (Glu342Lys) and made both the “M” and “Z” mouse PI2 α1AT proteins. We have tested the ability of a small-molecular-weight compound CG to alleviate polymerisation of these mouse α1AT proteins as it has been shown to reduce aggregates of Z α1AT in man. We found that (1) CG specifically reduces the formation of polymers of recombinant mouse “Z” protein but not “M” protein; (2) whereas there is significantly more α1AT secreted from Chinese Hamster Ovary cells transfected with the mouse “M” α1AT gene than with the “Z” (20.8 ± 3.9 and 6.7 ± 3.6, respectively; P < 0.005), CG increased the α1AT levels secreted from “Z” cells (21.2 ± 0.01) to that of “M” (20.2 ± 0.02). The data support the concept that the murine “Z” gene is a potential model for the study of α1ATD and that mice expressing this gene would be relevant for testing treatments in vivo.


  1. Ali R, Perfumo S, della Rocca C, Amicone L, Pozzi L, McCullagh P, Millward-Sadler H, Edwards Y, Povey S, Tripodi M (1998) Evaluation of a transgenic mouse model for alpha-1-antitrypsin (AAT)-related liver disease. Ann Hum Genet 58:305–320CrossRefGoogle Scholar
  2. Boriello F, Krauter KS (1991) Multiple murine alpha 1-protease inhibitor genes show unusual evolutionary divergence. Proc Natl Acad Sci USA 88:9417–9421CrossRefGoogle Scholar
  3. Brantly M, Nukiwa T, Crystal RG (1988) Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 24:13–31Google Scholar
  4. Burrows JA, Willis LK, Perlmutter DH (2000) Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci USA 97:1796–1801PubMedCrossRefGoogle Scholar
  5. Carlson JA, Rogers BB, Sifer RN, Finegold MJ, Clift SM, DeMayo FJ, Bullock DW, Woo SL (1989) Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest 83:1183–1190PubMedCrossRefGoogle Scholar
  6. Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, Boswell DR (1982) Structure and variation of human alpha 1-antitrypsin. Nature 298:329–334PubMedCrossRefGoogle Scholar
  7. Churg A, Wang RD, Xie C, Wright JL (2003) alpha-1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 168:199–207PubMedCrossRefGoogle Scholar
  8. Cichy J, Potempa J, Travis J (1997) Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem 272:8250–8255PubMedCrossRefGoogle Scholar
  9. Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA (2009) Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J 33:1345–1353PubMedCrossRefGoogle Scholar
  10. Elliott PR, Lomas DA, Carrell RW, Abrahams JP (1996) Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat Struct Biol 3:676–681PubMedCrossRefGoogle Scholar
  11. Eriksson S (1965) Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl 177:432Google Scholar
  12. Eriksson S, Carlson J, Velez R (1986) Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. New Engl J Med 31:736–739CrossRefGoogle Scholar
  13. Gotzsche PC, Johansen HK (2010) Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database Syst Rev 7:CD007851Google Scholar
  14. Irving JA, Pike RN, Lesk AM, Whisstock JC (2000) Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res 10:1845–1864PubMedCrossRefGoogle Scholar
  15. Janciauskiene S (2001) Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta 1535:221–235PubMedGoogle Scholar
  16. Koj A, Regoeczi E, Toews CJ, Leveille R, Gauldie J (1978) Synthesis of antithrombin III and alpha-1-antitrypsin by the perfused rat liver. Biochim Biophys Acta 539:496–504PubMedCrossRefGoogle Scholar
  17. Kushi A, Akiyama K, Noguchi M, Edamura K, Yoshida T, Sasai H (2004) Disruption of the murine alpha1-antitrypsin/PI2 gene. Exp Anim 53:437–443PubMedCrossRefGoogle Scholar
  18. Lomas DA, Evans DL, Finch JT, Carrell RW (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 18:605–607CrossRefGoogle Scholar
  19. Mahadeva R, Dafforn TR, Carrell RW, Lomas DA (2002) 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem 277:6771–6774PubMedCrossRefGoogle Scholar
  20. Mallya M, Phillips RL, Saldanha SA, Gooptu B, Leigh Brown SC, Termine DJ, Shirvani AM, Wu Y, Sifers RN, Abagyan R, Lomas DA (2007) Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates. J Med Chem 50:5357–5363PubMedCrossRefGoogle Scholar
  21. Martorana PA, Brand T, Gardi C, van Even P, de Santi MM, Calzoni P, Marcolongo P, Lungarella G (1993) The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency. Lab Invest 68:233–241PubMedGoogle Scholar
  22. McNab GL, Ahmad A, Mistry D, Stockley RA (2007) Modification of gene expression and increase in alpha1-antitrypsin (alpha1-AT) secretion after homologous recombination in alpha1-AT-deficient monocytes. Hum Gene Ther 18:1171–1177PubMedCrossRefGoogle Scholar
  23. Mornex JF, Chytil-Weir A, Martinet Y, Courtney M, LeCocq JP, Crystal RG (1986) Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. J Clin Invest 77:1952–1961PubMedCrossRefGoogle Scholar
  24. Paterson T, Moore S (1996) The expression and characterization of five recombinant murine alpha 1-protease inhibitor proteins. Biochem Biophys Res Commun 219:64–69PubMedCrossRefGoogle Scholar
  25. Potempa J, Korzus E, Travis J (1994) The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 269:15957–15960PubMedGoogle Scholar
  26. Ratner M (2010) Cochrane meta-analysis on alpha-1 antitrypsin prompts furor. Nat Biotechnol 28:885–886PubMedCrossRefGoogle Scholar
  27. Senior RM, Tegner H, Kuhn C, Ohlsson K, Starcher BC, Pierce JA (1977) The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis 116:469–475PubMedGoogle Scholar
  28. Silverman EK (2001) Genetics of chronic obstructive pulmonary disease. Novartis Found Symp 234:45–58PubMedCrossRefGoogle Scholar
  29. Sloan B, Abrams WR, Meranze DR, Kimbel P, Weinbaum G (1981) Emphysema induced in vitro and in vivo in dogs by a purified elastase from homologous leukocytes. Am Rev Respir Dis 124:295–301PubMedGoogle Scholar
  30. Snider GL, Lucey EC, Christensen TG, Stone PJ, Calore JD, Catanese A, Franzblau C (1984) Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am Rev Respir Dis 129:155–160PubMedGoogle Scholar
  31. Stockley RA, Parr DG, Piitulainen E, Stolk J, Stoel BC, Dirksen A (2010) Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res 11:136PubMedCrossRefGoogle Scholar
  32. van Gent D, Sharp P, Morgan K, Kalsheker N (2003) Serpins: structure, function and molecular evolution. Int J Biochem Cell Biol 35:1536–1547PubMedCrossRefGoogle Scholar
  33. Venembre P, Boutten A, Seta N, Dehoux MS, Crestani B, Aubier M, Durand G (1994) Secretion of alpha 1-antitrypsin by alveolar epithelial cells. FEBS Lett 346:171–174PubMedCrossRefGoogle Scholar
  34. Wang D, Wang W, Dawkins P, Paterson T, Kalsheker N, Sallenave JM, McGarry Houghton A (2011) Deletion of serpina1a, a murine α1-antitrypsin ortholog, results in embryonic lethality. Exp Lung Res 37(5):291–300PubMedCrossRefGoogle Scholar
  35. Wilczynska M, Fa M, Karolin J, Ohlsson PI, Johansson LB, Ny T (1997) Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat Struct Biol 4:354–357PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Gillian L. McNab
    • 1
  • Timothy R. Dafforn
    • 2
  • Alice Wood
    • 1
  • Elizabeth Sapey
    • 1
  • Robert A. Stockley
    • 3
  1. 1.Department of Respiratory Medicine, Centre for Translational InflammationUniversity of Birmingham Research Laboratories, Queen Elizabeth HospitalBirminghamUK
  2. 2.School of BiosciencesUniversity of BirminghamBirminghamUK
  3. 3.University Hospitals Birmingham, University of BirminghamBirminghamUK

Personalised recommendations